T

Treatment.com International Inc
CNSX:TRUE

Watchlist Manager
Treatment.com International Inc
CNSX:TRUE
Watchlist
Price: 0.89 CAD 5.95% Market Closed
Market Cap: CA$71.7m

Treatment.com International Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Treatment.com International Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
T
Treatment.com International Inc
CNSX:TRUE
Research & Development
-CA$479.7k
CAGR 3-Years
40%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Teladoc Health Inc
NYSE:TDOC
Research & Development
-$283.1m
CAGR 3-Years
5%
CAGR 5-Years
-26%
CAGR 10-Years
-37%
CorVel Corp
NASDAQ:CRVL
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alignment Healthcare LLC
NASDAQ:ALHC
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Accolade Inc
NASDAQ:ACCD
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Privia Health Group Inc
NASDAQ:PRVA
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Treatment.com International Inc
Glance View

Market Cap
71.7m CAD
Industry
N/A

Treatment.com International, Inc. engages in the research and development, business development of consumer health services delivered by mobile app technology. The company is headquartered in Bloomington, Minnesota. The company went IPO on 2021-04-19. The firm has developed an artificial intelligence (AI) platform to help patients and caregivers around the globe to make better health decisions. The firm offers treatment digital health application, which is driven by an intelligent digital health assistant that allows people to take control of their health. The company is a revolutionary symptom assessment tool. Its treatment mobile app provides specialist-level symptom checking, integrated medication logistics, and personalized curated assessments based on the individual user. The Company’s solutions include treatment clinical and treatment commercial. Its treatment clinical solutions include global library of medicine (GLM), treatment intelligent digital assistant, treatment triage, treatment dermatology, treatment ophthalmology and treatment medical education. Its treatment commercial solutions include rewards distribution, membership, and social network.

TRUE Intrinsic Value
0.01 CAD
Overvaluation 99%
Intrinsic Value
Price
T

See Also

What is Treatment.com International Inc's Research & Development?
Research & Development
-479.7k CAD

Based on the financial report for Dec 31, 2024, Treatment.com International Inc's Research & Development amounts to -479.7k CAD.

What is Treatment.com International Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-8%

Over the last year, the Research & Development growth was -35%. The average annual Research & Development growth rates for Treatment.com International Inc have been 40% over the past three years , -8% over the past five years .

Back to Top